Abstract:Objective The gut microbiota plays a critical role in the appropriate development and maintenance of the enteric nervous system (ENS). Esophageal achalasia (EA) is a rare motility disorder characterized by the selective degeneration of inhibitory neurons in the esophageal myenteric plexus. This study aimed to evaluate the composition of the esophageal microbiota in achalasia and explore the potential microbial mechanisms involved in its pathogenesis. Design The lower esophageal mucosal microbiota was analyzed in patients with achalasia and control participants using 16 S rRNA sequencing. The association between the esophageal microbiota and achalasia was validated by inducing esophageal dysbiosis in C57BL/10 J and C57BL/10ScNJ (TLR4KO) mice via chronic exposure to ampicillin sodium in their drinking water. Results The esophageal microbiota in EA patients had lower diversity and a predominance of Gram-negative bacteria (Type II microbiota) compared to that in the healthy controls. Additionally, the relative abundance of Rhodobacter decreased significantly in patients with achalasia, which correlated with an enrichment of lipopolysaccharide (LPS) biosynthesis based on the COG database. Antibiotic-treated mice showed an esophageal microbiota characterized by increased abundance of Gram-negative bacteria (Type II microbiome), decreased abundance of Rhodobacter, and enriched LPS biosynthesis. Compared to the control and TLR4KO mice, the antibiotic-treated wild-type mice had higher LES resting pressure, increased LES contraction rate after carbachol stimulation, and decreased relaxation response to L-arginine. Moreover, the number of myenteric neurons decreased, while the number of lamina propria macrophages (LpMs) increased after antibiotic exposure. Furthermore, the TLR4-MYD88-NF-κB pathway was up-regulated, and the production of TNF-α, IL-1β, and IL-6 increased in the antibiotic-treated mice. Conclusions Patients with achalasia exhibit esophageal dysbiosis, which may induce aberrant esophageal motility.

The interplay between alterations in esophageal microbiota associated with Th17 immune response and impaired LC20 phosphorylation in achalasia

The Role of Type II Esophageal Microbiota in Achalasia: Activation of Macrophages and Degeneration of Myenteric Neurons

Imbalance of Innate and Adaptive Immunity in Esophageal Achalasia.

Comparison of Oral and Esophageal Microbiota in Patients with Achalasia Before and After Peroral Endoscopic Myotomy

Improvement of Endoscopical Therapy for Achalasia

LncRNA expression in idiopathic achalasia: New insight and preliminary exploration into pathogenesis

A single-cell transcriptional landscape of immune cells shows disease-specific changes of T cell and macrophage populations in human achalasia

A Cross‐sectional Study Reveals a Chronic Low‐grade Inflammation in Achalasia

Multiplex immunoassays reveal increased serum cytokines and chemokines associated with the subtypes of achalasia

Achalasia: The Current Clinical Dilemma and Possible Pathogenesis

Gene Expression Dysregulated of Long Chain Non-coding RNA in Patients with Idiopathic Achalasia: New Insight into Pathogenesis

Association of circulating cytokine levels and tissue-infiltrating myeloid cells with achalasia: results from Mendelian randomization and validation through clinical characteristics and single-cell RNA sequencing

The molecular pathogenesis of achalasia: a paired lower esophageal sphincter muscle and serum 4D label-free proteomic study

Docking Proteins Upregulate IL-1β Expression in Lower Esophageal Sphincter Muscle in Esophageal Achalasia

Exploring the Neural Mechanisms Underlying Achalasia: A Study of Functional Connectivity and Regional Brain Activity.

Eosinophils Infiltration in Esophageal Muscularis Propria Induces Achalasia-like Esophageal Motility Disorder in Mice

Mast Cell Infiltration Associated with Loss of Interstitial Cells of Cajal and Neuronal Degeneration in Achalasia

The Etiology Of Achalasia: An Immune-Dominant Disease

RNA-sequencing reveals molecular and regional differences in the esophageal mucosa of achalasia patients

Aflatoxin Influences Achalasia Symptomatology

Plasma levels of TNF-α, IL-6, IFN-γ, IL-12, IL-17, IL-22, and IL-23 in achalasia, eosinophilic esophagitis (EoE), and gastroesophageal reflux disease (GERD)